Approval · Notice of Compliance 19638 · 2017
ANAFRANIL: Notice of Compliance 19638
Issued August 4, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19638
- Date
- August 4, 2017
- Company
- AA Pharma Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Transfer of Drug Identification Numbers
Products in this notice
Medicinal ingredients
- CLOMIPRAMINE HCL 10 MG per TAB
- CLOMIPRAMINE HCL 25 MG per TAB
- CLOMIPRAMINE HCL 50 MG per TAB